ALDOA and hepatocellular carcinoma: Considering the heterogeneity of HCC patients, subgroup analysis was performed based on tumor-node-metastasis (TNM) stage and demonstrated that ALDOA overexpression was consistently associated with poor survival regardless of TNM stage (Fig. S7D).